Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (31-40 of 339) with videos related to

Pageof 34
Sort By:
Blood|August 20, 2013
The biology and clinical impact of genetic lesions in myeloid malignanciesR Coleman Lindsley, Benjamin L Ebert
The New England Journal of Medicine|March 29, 2018
Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid LeukemiaDavid P Steensma, Benjamin L Ebert
Current Opinion in Cell Biology|October 30, 2015
Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyondAndrew A Guirguis, Benjamin L Ebert
JACC. Cardiooncology|May 2, 2022
Leukemia and Heart Disease: Lessons at the Intersection of the Most Feared CHIP OutcomesPhilipp J Rauch, Benjamin L Ebert
Pediatric Blood & Cancer|April 4, 2009
Therapeutic potential of targeting haploinsufficient genes in cancerKevin J Cheung, Benjamin L Ebert
Blood|August 12, 2017
Prevalent premalignancyAdam S Sperling, Benjamin L Ebert
Nature|September 5, 2017
Leukaemia: Vitamin C regulates stem cells and cancerPeter G Miller, Benjamin L Ebert
Journal of the National Cancer Institute|September 11, 2019
CHIPing Away at Breast CancerAdam S Sperling, Benjamin L Ebert
Cell Stem Cell|April 3, 2026
Endogenous aldehydes: A driver of clonal hematopoiesis from within?Joanne I Hsu, Benjamin L Ebert
Experimental Hematology|December 16, 2019
Clonal hematopoiesis as a model for premalignant changes during agingDavid P Steensma, Benjamin L Ebert
Pageof 34

Showing results (31-40 of 339) with videos related to

Sort By:
Pageof 34
Blood|August 20, 2013
The biology and clinical impact of genetic lesions in myeloid malignanciesR Coleman Lindsley, Benjamin L Ebert
The New England Journal of Medicine|March 29, 2018
Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid LeukemiaDavid P Steensma, Benjamin L Ebert
Current Opinion in Cell Biology|October 30, 2015
Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyondAndrew A Guirguis, Benjamin L Ebert
JACC. Cardiooncology|May 2, 2022
Leukemia and Heart Disease: Lessons at the Intersection of the Most Feared CHIP OutcomesPhilipp J Rauch, Benjamin L Ebert
Pediatric Blood & Cancer|April 4, 2009
Therapeutic potential of targeting haploinsufficient genes in cancerKevin J Cheung, Benjamin L Ebert
Blood|August 12, 2017
Prevalent premalignancyAdam S Sperling, Benjamin L Ebert
Nature|September 5, 2017
Leukaemia: Vitamin C regulates stem cells and cancerPeter G Miller, Benjamin L Ebert
Journal of the National Cancer Institute|September 11, 2019
CHIPing Away at Breast CancerAdam S Sperling, Benjamin L Ebert
Cell Stem Cell|April 3, 2026
Endogenous aldehydes: A driver of clonal hematopoiesis from within?Joanne I Hsu, Benjamin L Ebert
Experimental Hematology|December 16, 2019
Clonal hematopoiesis as a model for premalignant changes during agingDavid P Steensma, Benjamin L Ebert
Pageof 34